Article (Scientific journals)
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry.
Hong, Young Joon; Jeong, Myung Ho; Abizaid, Alexander et al.
2011In JACC. Cardiovascular Interventions, 4 (9), p. 982-91
Peer Reviewed verified by ORBi
 

Files


Full Text
HONG sirolimus elutih coronary stents in 80.pdf
Publisher postprint (1.08 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary/adverse effects/instrumentation/mortality; Australia; Cardiovascular Agents/administration & dosage; Drug-Eluting Stents; Europe; Female; Fibrinolytic Agents/therapeutic use; Humans; Internet; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction/etiology; North America; Patient Selection; Platelet Aggregation Inhibitors/therapeutic use; Product Surveillance, Postmarketing; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus/administration & dosage; South America; Thrombosis/etiology; Time Factors; Treatment Outcome
Abstract :
[en] OBJECTIVES: The aim of this study was to identify the worldwide practice of Cypher Select (Cordis Corporation, Bridgewater, New Jersey) or Cypher Select Plus sirolimus-eluting stent (SES) in patients 80 years of age (octogenarian) and to identify clinical outcomes in this patient population. BACKGROUND: The use of drug-eluting stents in elderly patients may have different features compared with younger patients. METHODS: Between 2006 and 2008, 15,147 patients from 320 hospitals in 56 countries were enrolled in a registry. Initial implantation and follow-up outcome information obtained at 1-year follow-up in 675 octogenarian patients were compared with those in 14,472 nonoctogenarian patients. RESULTS: Octogenarians had significantly more comorbidities and had higher Charlson comorbidity index scores (1.5 +/- 1.6 vs. 1.0 +/- 1.3, p < 0.001). Rates of cardiac death (3.3% vs. 0.9%, p < 0.001), myocardial infarction (2.3% vs. 1.9%, p = 0.021), and definite or probable stent thrombosis (2.3% vs. 0.9%, p = 0.0002), and major bleeding (2.0% vs. 0.9%, p = 0.015) were significantly higher in octogenarians at 1 year; however, there was no significant difference in the rate of target lesion revascularization between the 2 groups (3.2% vs. 2.2%, p = 0.12). In octogenarians, a high Charlson comorbidity index was an independent predictor of death and stent thrombosis up to 360 days from the index procedure (hazard ratio: 1.3, 95% confidence interval: 1.1 to 1.5, p < 0.001, and hazard ratio: 1.5, 95% confidence interval: 1.3 to 1.8, p < 0.001, respectively). CONCLUSIONS: Stenting with SES may be an effective therapeutic option in elderly patients, with acceptable rates of complications and a very low rate of repeat revascularization as demonstrated by this e-SELECT (A Multi-Center Post-Market Surveillance Registry) subgroup analysis.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Hong, Young Joon
Jeong, Myung Ho
Abizaid, Alexander
Banning, Adrian
Bartorelli, Antonio
Dzavik, Vladimir
Ellis, Stephen G.
Gao, Runlin
Holmes, David R. Jr
Legrand, Victor ;  Université de Liège - ULiège > Département des sciences cliniques > Cardiologie
Neumann, Franz-Josef
Spaulding, Christian
Worthley, Stephen
Urban, Philip
More authors (4 more) Less
Language :
English
Title :
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry.
Publication date :
2011
Journal title :
JACC. Cardiovascular Interventions
ISSN :
1936-8798
eISSN :
1876-7605
Publisher :
Elsevier, Netherlands
Volume :
4
Issue :
9
Pages :
982-91
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright (c) 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Available on ORBi :
since 26 May 2014

Statistics


Number of views
65 (1 by ULiège)
Number of downloads
118 (0 by ULiège)

Scopus citations®
 
10
Scopus citations®
without self-citations
7
OpenCitations
 
9

Bibliography


Similar publications



Contact ORBi